Transition to dolutegravir-based ART in 35 low- and middle-income countries : a global survey of HIV care clinics.

hiv infections -- drug therapy -- developing countries, antiretroviral therapy -- developing countries, dolutegravir (drug) -- therapeutic use, sdg 3 – good health and well-being, sdg 10 – reduced inequalities, sdg 17 – partnerships for the goals